Axion BioSystems raises $6M


What does Axion BioSystems do?

Axion Biosystems, is a manufacturer of the Maestro multi-well micro electrode array platform.  This life science company develops technologies which solves issues related to brain activity and human heart. The company develops multi-electrode technology for providing access to cellular info analysis for clinical, research and drug discovery markets. The company offers single well systems, recording and stimulating channels, multi-well systems, channel systems and integrated circuits to eliminate stimulation artificacts.

How much Axion BioSystems was funded?

The company raised $6M in undisclosed round on May 16, 2016 from the investor Georgia Research Alliance.

Previous funding

  • $1M in undisclosed round on April 30, 2009
  • $2.1M in undisclosed round on July 16, 2010
  • $3.21M in undisclosed round on May 9, 2012

What is next for Axion BioSystems?

Axion BioSystems’s products are being adopted globally at increasing rate and to maintain its rapid growth, the company is planning to further invest in its worldwide sales channel and in the support system to expand its list of customers in biotech, pharma, governments and academia. The company plans on using the latets funding for accelerating the growth of its core life science instrumentation product line. The company has announced that Jay Teich will join its Board of Directors. Teich is the former CEO of Seahorse Bioscience. Both Axion and Seahorse have harnessed new technology for simplifying a complex measurement of cellular activity. their tools adoption is enabling exciting scientific discoveries while creating  a good growth market.

More about Axion BioSystems

The company is a proud member of biotech community of Atlanta. It was born out of tech developed at Georgia Tech. The company has its headquarters in Atlanta, GA. This life science instrumentation company develops high throughput micro electrode array systems for cellular analysis. This allows researchers in recreating heartbeats and brain activity on the benchtop.